This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Dizal (Jiangsu) Pharmaceutical Co., Ltd., Nvidia Corporation. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013-2026
Title: Yu Bai: Innovator in Antibody Development and Integrated Circuit Verification
Introduction
Yu Bai is a prominent inventor based in Shanghai, China. He has made significant contributions to the fields of biotechnology and integrated circuit design. With a total of 2 patents, his work focuses on innovative solutions that enhance performance and reliability in these areas.
Latest Patents
Among his latest patents is the development of novel anti-FGFR2B antibodies. This advancement holds potential for therapeutic applications in various medical conditions. Additionally, he has created a method for verifying the performance model of an integrated circuit. This method involves obtaining statistical request numbers and corresponding latency values of memory access requests. It further includes developing functions of latency values based on these statistics, retrieving latency values through random values, and verifying the logic of the performance model using the retrieved latency values.
Career Highlights
Yu Bai has worked with notable companies such as Nvidia Corporation and Dizal Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to cutting-edge projects in technology and pharmaceuticals.
Collaborations
Yu has collaborated with esteemed colleagues, including Reuel William Nash and Xiaowei Li. Their combined expertise has fostered an environment of innovation and creativity in their respective fields.
Conclusion
Yu Bai is a distinguished inventor whose work in antibody development and integrated circuit verification showcases his commitment to advancing technology. His contributions continue to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile